An innovative phase I study in healthy subjects to determine the mass balance, elimination, metabolism, and absolute bioavailability of mitapivat
Abstract Mitapivat, a first‐in‐class, oral, small‐molecule, allosteric activator of the red blood cell‐specific form of pyruvate kinase (PKR), was approved for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. In this phase I mass balance study in healthy males, we ad...
Main Authors: | Chandra Prakash, Heidi Mangus, Yan Yan, Hua Yang, Varsha Iyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13609 |
Similar Items
-
Safety, Pharmacokinetics/Pharmacodynamics, and Absolute Bioavailability of Dexmedetomidine Hydrochloride Nasal Spray in Healthy Subjects: A Randomized, Parallel, Escalating Dose Study
by: Yun Kuang, et al.
Published: (2022-05-01) -
Modifications of the Method for Calculating Absolute Drug Bioavailability
by: Wei Jiang, et al.
Published: (2016-05-01) -
Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants
by: Sibel Ucpinar, et al.
Published: (2023-07-01) -
S273: EVIDENCE OF NONINFERIORITY OF MITAPIVAT VERSUS SPLENECTOMY IN MURINE HEREDITARY SPHEROCYTOSIS
by: A. Matte’, et al.
Published: (2022-06-01) -
The Pharmacokinetic and Absolute Bioavailability of Cyclosporine (Atopica for Cats<sup>®</sup>) in Cats
by: Jingyuan Kong, et al.
Published: (2023-06-01)